Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 413 results for "cadila health"

Cadila recalls 15,144 bottles of anti-hypertension drug in US
Livemint.com

Buy Cadila Health, target of Rs 1,763: Nomura

Reiterate buy on Cadila Healthcare with a revised target price of R1,763 from R 1,218 earlier. We value Cadila's earnings ex-Asacol HD at 19x (from 18x earlier) FY17f EPS of R85.2 per share to arrive at our base business value of R1,619 per share. Financial Express, 6 days ago
Cadila Healthcare recalls cough treatment drug in US Indian-Commodity, 2 weeks ago
Cadila recalls 19,536 bottles of cough treatment drug in US Business Standard India, 2 weeks ago
[x]  
Business Standard India

Wockhardt, Cadila and Hospira voluntarily recall drugs in US

NEW DELHI: Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in the US, according to the US Food and Drug Administration (USFDA). As per the information available on the USFDA website, Wockhardt ...
 Economic Times3 weeks ago Trio recall drugs in US  Calcutta Telegraph3 weeks ago Three drugs firms recall select lot of drugs in the U.S.  The Hindu3 weeks ago Wockhardt, Cadila, Hospira recall drugs in the US  Business Standard India3 weeks ago
[x]  
Business Today India

Cadila launches cut-price version of world's top-selling drug

Mumbai. — Indian drug-maker Cadila Healthcare Ltd said yesterday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its US price. The drug's branded version ...
 Zimbabwe Herald1 month ago Cadila launches cheaper copy of top-selling drug in India  Business Today India1 month ago Zydus launches world's first biosimilar of Adalimumab  Moneycontrol.com1 month ago India's Cadila launches first cheaper copy of world's top-selling drug  Yahoo! Finance1 month ago
[x]  

Cadila Healthcare unveils cheaper copy of top drug

Expecting sales between Rs 1 billion to Rs 2 billion from its biosimilar: Cadila Drugmaker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world’s top-selling drug, at ...
 Asian Age1 month ago

Cadila Healthcare advances despite recalling cough treatment drug in US

Cadila Healthcare is currently trading at Rs. 1705.65, up by 59.40 points or 3.61% from its previous closing of Rs. 1646.25 on the BSE. The scrip opened at Rs. 1662.35 and has touched a high and low of Rs. 1717.95 and Rs. 1662.35 respectively. So ...
 Arihant Capital2 weeks ago

Cadila Healthcare Ltd clarifies on voluntary recall of drugs in US

Posted On: 2015-01-01 00:28:49 The Exchange had sought clarification from Cadila Healthcare Ltd with respect to news appearing in Economic Times on December 31, 2014 titled "Wockhardt, Cadila & Hospira voluntarily recall drugs in US."Cadila ...
 Equity Bulls3 weeks ago Cadila recalls Benzonatate capsules from US markets  The Financial Chronicle1 month ago Wockhardt Ltd clarifies on recall of drugs in US  Equity Bulls3 weeks ago Empty capsules lead to Aurobindo drug recall  DNA India2 months ago

Cadila Healthcare gains on plan to develop vaccines for Congo Virus and Ebola Virus

Cadila Healthcare is currently trading at Rs. 1606.00, up by 7.65 points or 0.48% from its previous closing of Rs. 1598.35 on the BSE. The scrip opened at Rs. 1610.00 and has touched a high and low of Rs. 1619.00 and Rs. 1600.00 respectively. So ...
 Arihant Capital3 weeks ago Cadila Healthcare edges up on plans of developing vaccines for Congo Virus and Ebola Virus  Arihant Capital3 weeks ago
Financial Express

The Gujarat Model: Is it the way forward?

Gujarat has done very well in some sectors but with its health indicators still lagging behind, will it be the blueprint for the rest of India? By Raelene Kambli Sickle Cell Anemia Control Programme Gujarat's model of development has been ...
 Financial Express1 week ago

Market edges higher in late trade

Sensex was provisionally up 32.30 points or 0.12% to 27,240.91. The market breadth indicating the overall health of the market was negative. Shares of most pharmaceutical companies rose. IT stocks were mixed. Meanwhile, foreign portfolio investors ...
 Business Standard India1 month ago Sensex, Nifty hit six-week closing low  Business Standard India1 month ago Sensex settles above 29,000 for the first time  Business Standard India3 days ago
AhmedabadMirror.com

No economic development without good health: WHO

To boost the healthcare sector in Gujarat the state government signed more than 270 MoUs with hospitals and pharmaceutical companies at the seventh Vibrant Gujarat Global Investor Summit on Monday. The major companies included Gujarat Cancer ...
 AhmedabadMirror.com1 week ago Pharma: In the best of health  Hindu Business Line3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less